EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence

Larissa Milena de Moura Maia Senna, Mittermayer Barreto Santiago, Isabella Vargas de Souza Lima, Aníbal de Freitas Santos Júnior

Medicina Clínica · 2026

DOI: 10.1016/j.medcli.2026.107576 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Medicina Clínica, 2026. Verfasst von Larissa Milena de Moura Maia Senna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, State University of Bahia (UNEB), Salvador, Bahia, Brazil. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Lupus Erythematosus, Systemic, Immunosuppressive Agents. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Coordination for the improvement of Higher Education Personnel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedLupus Erythematosus, SystemicImmunosuppressive AgentsHumansFemaleAdultLongitudinal StudiesMaleRetrospective StudiesMiddle AgedTreatment OutcomeGlucocorticoidsPrednisoneSeverity of Illness IndexDrug Therapy, Combination

Stichwörter der Autor:innen

Ahorro de corticosteroidesBelimumabCorticosteroid-sparingEvidencia del mundo realLupus eritematoso sistémicoLupus nephritisNefritis lúpicaReal-world evidenceSystemic lupus erythematosus

Substanzen

belimumabAntibodies, Monoclonal, HumanizedImmunosuppressive AgentsGlucocorticoidsPrednisone

Autor:innen und Institutionen

  • Department of Life Sciences, State University of Bahia (UNEB), Salvador, Bahia, Brazil.
  • Federal University of Bahia, Professor Edgar Santos University Hospital, SER Clinic of Bahia, Brazil.
  • Department of Life Sciences, State University of Bahia (UNEB), Salvador, Bahia, Brazil. Electronic address: anibaljrr@uol.com.br.

Förderung

  • Coordination for the improvement of Higher Education Personnel

Zitieren

APA

de Moura Maia Senna, L. M., Barreto Santiago, M., de Souza Lima, I. V., & de Freitas Santos Júnior, A. (2026). Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence. Medicina Clínica. https://doi.org/10.1016/j.medcli.2026.107576

Vancouver

de Moura Maia Senna LM, Barreto Santiago M, de Souza Lima IV, de Freitas Santos Júnior A. Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence. Medicina Clínica. 2026. doi:10.1016/j.medcli.2026.107576

BibTeX
@article{deMouraMaiaSenna2026,
  author = {de Moura Maia Senna, Larissa Milena and Barreto Santiago, Mittermayer and de Souza Lima, Isabella Vargas and de Freitas Santos Júnior, Aníbal},
  title = {Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence},
  journal = {Medicina Clínica},
  year = {2026},
  doi = {10.1016/j.medcli.2026.107576}
}
Kostenlos starten →